USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/18003
Title: Preliminary results of the ENERGY study (Ean NEuro-covid ReGistrY) in the Republic of Moldova
Authors: Popa, Vera
Grosu, Oxana
Lisnic, Vitalie
Gavriliuc, Mihail
Odainic, Olesea
Manvelov, Anastasia
Cebotari, Ecaterina
Keywords: ENERGY;EAN;Registry;NeuroCOVID
Issue Date: 2021
Publisher: The Scientific Medical Association of the Republic of Moldova
Citation: POPA, Vera, GROSU, Oxana, LISNIC, Vitalie, GAVRILIUC, Mihail, ODAINIC, Olesea, et al. Preliminary results of the ENERGY study (Ean NEuro-covid ReGistrY) in the Republic of Moldova. In: The Moldovan Medical Journal. 2021, vol. 64, no 3 (Neuro Congress Issue), p. 22. ISSN 2537-6381.
Abstract: Background: ENERGY registry developed by the European Academy of Neurology studies neurological manifestations in patients with COVID-19 infections. Diomid Gherman Institute of Neurology and Neurosurgery joined these efforts in December 2020. The aim of the study was to present the Moldovan cohort of patients with COVID-19 infection and neurological manifestations registered in the ENERGY. Material and methods: The registry recorded demographic data, comorbidities, complications, neurological symptoms in confirmed COVID-19 patients. The patients were evaluated at 6 and 12 months by phone. Results: The Moldovan cohort of patients with COVID-19 and neurological manifestations by May 2021 consists of 168 patients (50.6% men and 49.4% women). Most patients (86.9%) had comorbidities, such as arterial hypertension – 83.3%, diabetes mellitus – 23.2 %, cardiovascular – 27.4 %, obesity – 21.4 %. History of neurological diseases with impact on patient’s health was dementia 3.0%, Parkinson’s disease – 1.2%, stroke – 19.0%, multiple sclerosis – 1.2%, neuromuscular disorder – 1.2%, neuropathy – 1.8%. Complications requiring medical intervention were dyspnea – 44.6%, pneumonia – 61.9%, cardiovascular – 7.1%, renal insufficiency – 1.2%, coagulation disorder – 4.2% and mechanical ventilation – 16.1%. New neurological findings in patients with COVID-19 infection were headache (24.4%), vertigo (14.3%), cognitive impairment (35.7%), stupor/coma (22.1%), stroke (62.5%), ataxia (11.4%), spinal cord disorder (7.2%), peripheral neuropathy (5.4%). Mortality rate in the cohort was 22.61%. Conclusions: The Moldovan cohort of patients with neurological manifestations during COVID-19 infections registered in the ENERGY registry presented most frequently at the emergency department with stroke, cognitive impairment and headache. They have many comorbidities, history of neurological diseases, complications during hospital stay and high mortality rate.
metadata.dc.relation.ispartof: The Moldovan Medical Journal
URI: http://moldmedjournal.md/wp-content/uploads/2021/09/Congres-Neuro-2021-Spaltul-11.pdf
http://repository.usmf.md/handle/20.500.12710/18003
ISSN: 2537-6381
2537-6373
Appears in Collections:The Moldovan Medical Journal, Vol. 64, No 3, September 2021

Files in This Item:
File Description SizeFormat 
Preliminary_results_of_the_ENERGY_study_Ean_NEuro_covid_ReGistrY.pdf75.23 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback